Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Combined light therapy improves eye health and quality of life for those with meibomian gland dysfunction.

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

STS01 1% effectively promotes hair regrowth with minimal side effects.

High-intensity phototechnology, especially with other treatments, effectively improves quality of life for diffuse alopecia patients.

Extracts improve hair growth in alopecia.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

The new method reliably identifies and measures different animal hair fibers in textiles.

MicroRNAs and AI can improve cashmere goat hair quality and aid in hair disorder diagnosis.

Digital imaging tools help accurately assess hair transplant candidates.

A traditional herbal mix from East Nusa Tenggara may help hair regrowth after chemotherapy.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

The tumescent technique makes hair micrografting more comfortable and efficient.

Co-trimoxazole may help treat autoimmune diseases.

Hair follicle analysis can track body changes from high-intensity interval training.

EISA uses enzymes to create precise nanostructures in cells, offering new ways to design adaptive materials and therapies.

AI in medicine raises many questions and concerns.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Infrared light might help treat stubborn alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The method effectively detects MeT and TP in dried blood spots after cream application.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

HPLC may detect prediabetes and diabetes earlier than Immunoturbidimetry because it shows higher A1c levels.